As overexpression of Bcl-2 leads to the failure of apoptosis of B lymphocytes in mice [74,75] and also certain human B-cell lymphomas [76,77], we hypothesize that increased Bcl-2 expression in CAO samples prevents immune cell death. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.